Shares of biotechnology major Biocon today zoomed 10 per cent after the company reported a 47 per cent rise in consolidated net profit for the quarter ended June 2018.
Cheering the numbers, the stock made a positive opening on the BSE and later jumped 9.81 per cent to Rs 614.
On NSE, shares of the company rose sharply by 10 per cent to Rs 614.45.
Biocon yesterday reported a 47 per cent rise in consolidated net profit to Rs 120 crore for the quarter ended June 2018 on account of robust performance across segments.
The company had posted a net profit of Rs 81 crore for the corresponding period of the previous fiscal, Biocon said in a filing to BSE.
Consolidated total revenue of the company stood at Rs 1,193 crore for the quarter under consideration. It was Rs 988 crore for the same period a year ago.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app